search
Back to results

COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray

Primary Purpose

COVID-19

Status
Withdrawn
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Hydrogen peroxide
Placebo
Sponsored by
EPISTATA
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for COVID-19

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

- recent positive SARS-CoV-2 PCER swab test

Exclusion Criteria:

- severe Covid19 disease

Sites / Locations

  • Clinica Nuova ITOR

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Active

Placebo

Arm Description

Mouth wash and nasal spray containing a diluted solution of hydrogen peroxide

Mouth wash and nasal spray not containing a diluted solution of hydrogen peroxide

Outcomes

Primary Outcome Measures

The negativisation rate of a positive SARS-CoV-2 (COVID-19) PCR nose swab test
A repeated SARS-CoV-2 PCR nose swab test after a previous positive SARS-CoV-2 PCR nose swab test

Secondary Outcome Measures

Full Information

First Posted
May 4, 2021
Last Updated
November 20, 2022
Sponsor
EPISTATA
search

1. Study Identification

Unique Protocol Identification Number
NCT04878042
Brief Title
COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray
Official Title
The Negativisation Rate of Positive PCR Swab Tests for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) After Treatment With Hydrogen Peroxide: a Double-blind Placebo-controlled Randomised Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Withdrawn
Why Stopped
No participants
Study Start Date
April 9, 2021 (Actual)
Primary Completion Date
June 2021 (Anticipated)
Study Completion Date
July 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
EPISTATA

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Hydrogen peroxide is produced physiologically by oral bacteria and plays a significant role in the balance of oral microecology since it is an important antimicrobial agent. In the epithelial cells, the enzyme superoxide dismutase catalyzes a reaction leading from hydrogen peroxide to the ion superoxide. The induced oxidative stress stimulates a local innate response via activation of the toll-like receptors and the NF-κB. Those kinds of reactions are also activated by viral infections. Virus-induced oxidative stress plays an important role in the regulation of the host immune system and the specific oxidant-sensitive pathway is one of the effective strategies against viral infections. Therefore, nose/mouth/throat washing with hydrogen peroxide may enhance those local innate responses to viral infections. The investigators hypothesised that a treatment with a mouth wash and a nasal spray containing a diluted solution of hydrogen peroxide may accelerate the negativisation rate of a positive PCR swab test for SARS-CoV-2 (COVID-19).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Active
Arm Type
Experimental
Arm Description
Mouth wash and nasal spray containing a diluted solution of hydrogen peroxide
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Mouth wash and nasal spray not containing a diluted solution of hydrogen peroxide
Intervention Type
Device
Intervention Name(s)
Hydrogen peroxide
Intervention Description
Mouth wash and nasal spray 3 times a day for 3 days
Intervention Type
Device
Intervention Name(s)
Placebo
Intervention Description
Mouth wash and nasal spray 3 times a day for 3 days
Primary Outcome Measure Information:
Title
The negativisation rate of a positive SARS-CoV-2 (COVID-19) PCR nose swab test
Description
A repeated SARS-CoV-2 PCR nose swab test after a previous positive SARS-CoV-2 PCR nose swab test
Time Frame
4 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: - recent positive SARS-CoV-2 PCER swab test Exclusion Criteria: - severe Covid19 disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio I Lazzarino, MD PhD
Organizational Affiliation
EPISTATA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Clinica Nuova ITOR
City
Roma
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray

We'll reach out to this number within 24 hrs